Resources

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Analytics

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.

Cookie	Duration	Description
_ga	2 years	The principal cookie that uses Google Analythics is "_ga", it allows to the services to distinguish a visitor for another one and it has a duration of 2 years. Every websites uses it that have implemented Google Analytics, and Google services are included
_ga_N6XRMTLNXH	2 years	Cookie used by Google Analythics

FGFR1 inhibitors stabilize different binding modes

Selectivity profiling of irreversible EGFR inhibitors using COVALfinder^®

COVALfinder^®, the ideal tool for irreversible drug discovery programs

Discovering and de-risking irreversible inhibitors

Designing selective irreversible inhibitors

Building better models to define therapeutic windows

The clinical significance of kinetic selectivity on ABL1 inhibitors

Exploring activation state-dependent kinetics to discover novel drugs

Affinity doesn’t tell the whole story of MET inhibitor Foretinib

Approved FLT3 drugs are kinetic and conformation selective